As the life sciences industry increasingly recognizes the importance of patient-centered evidence, in-trial interviews have emerged as a powerful tool for understanding patient experience, meaningful change, treatment burden, and outcomes from the patient’s perspective. But how do you gain multi-stakeholder buy-in, design, implement, and leverage these interviews effectively? What are the regulatory and HTA considerations? And how can these insights drive better decision-making throughout the development lifecycle?
Our webinar explores the strategic value and best practices of in-trial interviews — a critical methodology for capturing patient experience that can significantly benefit clinical development, regulatory submissions, and reimbursement decisions.
During the webinar we:
- Address common challenges and practical solutions
- Explore the strategic rationale and applications for in-trial interviews
- Share best practices for study design and implementation
- Discuss regulatory considerations and compliance requirements
- Present real-world case studies and lessons learned
Speakers:
Nathan Johnson
Director, Patient-Centered Outcomes, Lumanity
Laura Tesler Waldman
Senior Director, Patient-Centered Outcomes, Lumanity
Elizabeth Hribal
Associate Director, Patient-Centered Outcomes, Lumanity
Shayna Egan
Director, Endpoint Strategy and Development, Ultragenyx
